All Videos Channels
  1. Novo Nordisk's new obesity drug data disappoints again, shares fall

    Novo Nordisk's new obesity drug data disappoints again, shares fall

    502
  2. Novo Nordisk's Stock Dips: CagriSema Trial Results Shock Investors!

    Novo Nordisk's Stock Dips: CagriSema Trial Results Shock Investors!

    3
    1
  4. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    19
  5. Novo Nordisk wzywa nas do usunięcia filmów, pod groźbą kary!! Zaczęło się!

    Novo Nordisk wzywa nas do usunięcia filmów, pod groźbą kary!! Zaczęło się!

    78
    0
    2.5K
    3
  6. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    27
  7. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    20
  8. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    21
  9. Wegovy heart benefits due to more than weight loss -Novo Nordisk

    Wegovy heart benefits due to more than weight loss -Novo Nordisk

    4
    0
    2K
    1
  10. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    18
  11. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    21
  12. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    26
  13. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  14. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  15. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    20
  16. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    16
  17. Dr. Fatima Stamford, the Head of Obesity Research at Harvard is Paid Off by Novo Nordisk

    Dr. Fatima Stamford, the Head of Obesity Research at Harvard is Paid Off by Novo Nordisk

    103
    0
    5.47K
    9
  18. Novo Nordisk's New Obesity Drug: Game Changer? #shorts

    Novo Nordisk's New Obesity Drug: Game Changer? #shorts

    12